Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $75.2B
1-Year Return 41.49%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Quarter Return
+3.09%
1 Year Return
+41.49%
3 Year Return
+105.58%
5 Year Return
+199.51%
10 Year Return
+593.04%
AUM
$114B
AUM Growth
+$3.58B
Cap. Flow
+$1.67B
Cap. Flow %
1.47%
Top 10 Hldgs %
9.08%
Holding
3,913
New
498
Increased
1,853
Reduced
1,145
Closed
399

Sector Composition

1 Healthcare 17.59%
2 Technology 14.12%
3 Financials 10.92%
4 Consumer Discretionary 9.85%
5 Real Estate 7.99%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
EXPI icon
3301
eXp World Holdings
EXPI
$1.82B
$205K ﹤0.01%
+36,800
New +$205K
HIND
3302
Vyome Holdings, Inc. Common Stock
HIND
$174M
0
-$139K
SBFG icon
3303
SB Financial Group
SBFG
$134M
$201K ﹤0.01%
12,811
-2,519
-16% -$39.5K
FBRX icon
3304
Forte Biosciences
FBRX
$164M
$196K ﹤0.01%
78
+4
+5% +$10.1K
PEY icon
3305
Invesco High Yield Equity Dividend Achievers ETF
PEY
$1.12B
$196K ﹤0.01%
+10,800
New +$196K
ARTX
3306
DELISTED
Arotech Corporation
ARTX
$196K ﹤0.01%
98,606
+43,906
+80% +$87.3K
MAMS
3307
DELISTED
MAM Software Group Inc. New
MAMS
$191K ﹤0.01%
18,800
-1,400
-7% -$14.2K
MRUS icon
3308
Merus
MRUS
$5.21B
$190K ﹤0.01%
13,000
-3,000
-19% -$43.8K
TNXP icon
3309
Tonix Pharmaceuticals
TNXP
$249M
0
-$250K
NEXT icon
3310
NextDecade
NEXT
$1.69B
$190K ﹤0.01%
30,100
+5,200
+21% +$32.8K
PRVB
3311
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$189K ﹤0.01%
+15,600
New +$189K
DARE icon
3312
Dare Bioscience
DARE
$28M
$187K ﹤0.01%
18,287
+3,425
+23% +$35K
MFH
3313
Mercurity Fintech Holding
MFH
$682M
$187K ﹤0.01%
59,110
+5,040
+9% +$15.9K
VIRX
3314
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$187K ﹤0.01%
7,358
+5,597
+318% +$142K
DUST icon
3315
Direxion Daily Gold Miners Index Bear 2X Shares
DUST
$58.2M
$185K ﹤0.01%
+65
New +$185K
CCLD icon
3316
CareCloud
CCLD
$149M
$184K ﹤0.01%
+36,500
New +$184K
MYOV
3317
DELISTED
Myovant Sciences Ltd.
MYOV
$184K ﹤0.01%
+20,300
New +$184K
NEOS
3318
DELISTED
Neos Therapeutics, Inc
NEOS
$183K ﹤0.01%
141,555
+34,587
+32% +$44.7K
SUMR
3319
DELISTED
Summer Infant, Inc.
SUMR
$182K ﹤0.01%
40,490
+200
+0.5% +$899
AVTX icon
3320
Avalo Therapeutics
AVTX
$156M
$181K ﹤0.01%
+12
New +$181K
MJCO
3321
DELISTED
Majesco
MJCO
$181K ﹤0.01%
19,400
-1,100
-5% -$10.3K
COE
3322
51Talk Online Education Group
COE
$265M
$180K ﹤0.01%
5,975
+2,775
+87% +$83.6K
AHPI
3323
DELISTED
Allied Healthcare Products
AHPI
$179K ﹤0.01%
95,240
+3,100
+3% +$5.83K
IDN icon
3324
Intellicheck
IDN
$110M
$175K ﹤0.01%
+30,304
New +$175K
CFRX
3325
DELISTED
ContraFect Corporation
CFRX
$175K ﹤0.01%
429
+153
+55% +$62.4K